当前位置: 首页 > 期刊 > 《中国医学创新》 > 2025年第19期
编号:2390624
烯丙雌醇片联合醋酸阿托西班治疗常规保胎失败的晚期先兆流产患者的效果和安全性分析
http://www.100md.com 2025年8月10日 中国医学创新 2025年第19期
    

    EffectandSafetyAnalysisof AllylEstradiolTablets Combined withAtosibanAcetatein theTreatment ofPatientswith Advanced Threatened AbortionWho Failed to Conventional Tocolytic Therapy/LEI Yanling.//MedicalInnovationofChina,2025,22(19):103-107

    [Abstract]Objective:To analyze the effect and safetyof AllylEstradiol Tablets combined with Atosiban Acetate in the treatmentof patients with advanced threatened abortion who failed to conventional tocolytic therapy. Method:Aretrospective analysis was conducted on the clinical data of 82 patients with advanced threatened abortion who failed to conventional tocolytic therapy inthe Departmentof Obstetrics of Zibo Maternal and Child Health Hospital fromFebruary 202 to February 2O24,they were divided into the control group (n=41)and the observation group (n=41)according todifferent treatment methods.Thecontrol group was givenoral AlylEstradiol Tablets,and the observation group was given intravenous infusion of Atosiban Acetate on the basis of the control group.The success rate offetal preservation and drug safety ......

您现在查看是摘要页,全文长 14608 字符